Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Total Liabilities 2010–2025
Supernus Pharmaceuticals Inc. annual/quarterly total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Supernus Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 390.9M, a 17.63% increase year-over-year.
- Supernus Pharmaceuticals Inc. total liabilities for 2025 were 390.9M, a 17.63% increase from 2024.
- Supernus Pharmaceuticals Inc. total liabilities for 2024 were 332.3M, a 6.69% decrease from 2023.
- Supernus Pharmaceuticals Inc. total liabilities for 2023 were 356.2M, a 56.37% decrease from 2022.
- Supernus Pharmaceuticals Inc. total liabilities for 2022 were 816.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Supernus Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $391 |
| 2024 | $332 |
| 2023 | $356 |
| 2022 | $816 |
| 2021 | $873 |
| 2020 | $759 |
| 2019 | $565 |
| 2018 | $525 |
| 2017 | $157 |
| 2016 | $118 |
| 2015 | $101 |
| 2014 | $96 |
| 2013 | $78 |
| 2012 | $36 |
| 2011 | $44 |
| Supernus Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $391 |
| 2024-12-31 | $332 |
| 2023-12-31 | $356 |
| 2022-12-31 | $816 |
| 2021-12-31 | $873 |
| 2020-12-31 | $759 |
| 2019-12-31 | $565 |
| 2018-12-31 | $525 |
| 2017-12-31 | $157 |
| 2016-12-31 | $118 |
| 2015-12-31 | $101 |
| 2014-12-31 | $96 |
| 2013-12-31 | $78 |
| 2012-12-31 | $36 |
| 2011-12-31 | $44 |
Supernus Pharmaceuticals Inc. Total Liabilities — FAQ
Supernus Pharmaceuticals Inc. (SUPN) total liabilities over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SUPN's total liabilities history?
The chart and table above show Supernus Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.